|
LOC729176 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.57480000548571E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.177900E-04 |
| Normal-vs-Stage2 |
8.220100E-03 |
| Normal-vs-Stage3 |
4.81930000351127E-08 |
| Normal-vs-Stage4 |
8.53079999973971E-07 |
| Stage1-vs-Stage2 |
9.420400E-01 |
| Stage1-vs-Stage3 |
6.495700E-03 |
| Stage1-vs-Stage4 |
3.462100E-02 |
| Stage2-vs-Stage3 |
1.276770E-01 |
| Stage2-vs-Stage4 |
1.951960E-01 |
| Stage3-vs-Stage4 |
7.942000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.79930000010486E-07 |
| Normal-vs-AfricanAmerican |
1.5872000003192E-07 |
| Normal-vs-Asian |
6.026400E-01 |
| Caucasian-vs-AfricanAmerican |
3.955900E-02 |
| Caucasian-vs-Asian |
2.076000E-01 |
| AfricanAmerican-vs-Asian |
2.550100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.63049999455123E-08 |
| Normal-vs-Female |
1.9051299999906E-05 |
| Male-vs-Female |
1.648970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.295000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.75121000000056E-05 |
| Normal-vs-Age(61-80Yrs) |
2.54050000003669E-06 |
| Normal-vs-Age(81-100Yrs) |
2.155900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.310400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.904200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.172400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.740400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.514600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.186000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.560980E-01 |
| Normal-vs-Grade 2 |
1.480950E-03 |
| Normal-vs-Grade 3 |
8.01930000182693E-08 |
| Normal-vs-Grade 4 |
8.62570004311891E-09 |
| Grade 1-vs-Grade 2 |
9.217800E-01 |
| Grade 1-vs-Grade 3 |
1.180180E-01 |
| Grade 1-vs-Grade 4 |
2.902300E-02 |
| Grade 2-vs-Grade 3 |
2.846700E-04 |
| Grade 2-vs-Grade 4 |
3.97220000000198E-05 |
| Grade 3-vs-Grade 4 |
1.493840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.996410E-03 |
| Normal-vs-ccB subtype |
1.94790000018763E-07 |
| ccA subtype-vs-ccB subtype |
5.384600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.02440000000026E-05 |
| Normal-vs-N1 |
3.242400E-03 |
| N0-vs-N1 |
2.452800E-01 |
|
|
